Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection
Authors
Keywords
Astrocytes, Neurons, Fluorescence imaging, Cerebellum, Hippocampus, Neostriatum, Olfactory bulb, In vivo imaging
Journal
PLoS One
Volume 12, Issue 12, Pages e0188830
Publisher
Public Library of Science (PLoS)
Online
2017-12-16
DOI
10.1371/journal.pone.0188830
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z -Q175-KI Huntington's disease mice
- (2016) Tatyana Vagner et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington’s disease
- (2015) B Connor et al. GENE THERAPY
- Adeno-associated viral serotypes produce differing titers and differentially transduce neurons within the rat basal and lateral amygdala
- (2014) Roopashri Holehonnur et al. BMC NEUROSCIENCE
- Overexpression of the Astrocyte Glutamate Transporter GLT1 Exacerbates Phrenic Motor Neuron Degeneration, Diaphragm Compromise, and Forelimb Motor Dysfunction following Cervical Contusion Spinal Cord Injury
- (2014) K. Li et al. JOURNAL OF NEUROSCIENCE
- Advanced CLARITY for rapid and high-resolution imaging of intact tissues
- (2014) Raju Tomer et al. Nature Protocols
- Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection
- (2014) Jesse R. McLean et al. NEUROSCIENCE LETTERS
- Chronic Treatment with Novel Small Molecule Hsp90 Inhibitors Rescues Striatal Dopamine Levels but Not α-Synuclein-Induced Neuronal Cell Loss
- (2014) Nikolaus R. McFarland et al. PLoS One
- Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuitsin vivo
- (2013) Ji-Yoen Kim et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
- (2013) Paramita Chakrabarty et al. PLoS One
- Glial Promoter Selectivity following AAV-Delivery to the Immature Brain
- (2013) Georg von Jonquieres et al. PLoS One
- Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
- (2013) Dominik F. Aschauer et al. PLoS One
- Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors
- (2013) Nicolas Merienne et al. Frontiers in Cellular Neuroscience
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice
- (2011) T Kiyota et al. GENE THERAPY
- Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
- (2011) Steven J Gray et al. MOLECULAR THERAPY
- Efficient Gene Therapy for Parkinson's Disease Using Astrocytes as Hosts for Localized Neurotrophic Factor Delivery
- (2011) Anja Drinkut et al. MOLECULAR THERAPY
- 1,3-Dinitrobenzene–Induced Metabolic Impairment through Selective Inactivation of the Pyruvate Dehydrogenase Complex
- (2011) James A. Miller et al. TOXICOLOGICAL SCIENCES
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system
- (2009) Nikolaus R. McFarland et al. JOURNAL OF NEUROCHEMISTRY
- Efficient Gene Delivery and Selective Transduction of Glial Cells in the Mammalian Brain by AAV Serotypes Isolated From Nonhuman Primates
- (2009) Patricia A Lawlor et al. MOLECULAR THERAPY
- AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice
- (2009) Tomomi Kiyota et al. MOLECULAR THERAPY
- Gene Therapy Using Adeno-Associated Virus Vectors
- (2008) S. Daya et al. CLINICAL MICROBIOLOGY REVIEWS
- GFAPpromoter elements required for region-specific and astrocyte-specific expression
- (2008) Youngjin Lee et al. GLIA
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity
- (2007) Nicolas C. Royo et al. BRAIN RESEARCH
- Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro
- (2007) Douglas B. Howard et al. VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started